Breast cancer cases with HER2 amplification and/or overexpression show up to 25–50 copies of the HER2 gene, and 40–100-fold increase in HER2 protein resulting in two million receptors expressed at the cell surface (Slamon et al., 1989). This evidence concerns the gene ERBB2 and breast carcinoma.